References
Jinnin M. Recent progress in studies of miRNA and skin diseases. J Dermatol 2015; 42: 551–8.
Xia J, Zhang W. MicroRNAs in normal and psoriatic skin. Physiol Genomics 2014; 46: 113–22.
Oyama R, Jinnin M, Kakimoto A, et al. Circulating microRNA associated with TNF-alpha signaling pathway in patients with plaque psoriasis. J Dermatol Sci 2011; 61: 209–11.
Ichihara A, Jinnin M, Oyama R, et al. Increased serum levels of miR-1266 in patients with psoriasis vulgaris. Eur J Dermatol 2012; 22: 68–71.
Pivarcsi A, Meisgen F, Xu N, Stahle M, Sonkoly E. Changes in the level of serum microRNAs in patients with psoriasis after antitumour necrosis factor-alpha therapy. Br J Dermatol 2013; 169: 563–70.
Guo S, Zhang W, Wei C, et al. Serum and skin levels of miR-369-3p in patients with psoriasis and their correlation with disease severity. Eur J Dermatol 2013; 23: 608–13.
Garcia-Rodriguez S, Arias-Santiago S, Orgaz-Molina J, et al. Abnormal levels of expression of plasma microRNA-33 in patients with psoriasis. Actas Dermosifiliogr 2014; 105: 497–503.
Koga Y, Jinnin M, Ichihara A, et al. Analysis of expression pattern of serum microRNA levels in patients with psoriasis. J Dermatol Sci 2014; 74: 170–1.
Løvendorf MB, Zibert JR, Gyldenlove M, Ropke MA, Skov L. MicroRNA-223 and miR-143 are important systemic biomarkers for disease activity in psoriasis. J Dermatol Sci 2014; 75: 133–9.
Tsoi LC, Spain SL, Knight J, et al. Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity. Nat Genet 2012; 44: 1341–8.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Van Gele, M., Bracke, S., De Alves Medeiros, A.K. et al. Exploring the feasibility of whole blood to identify systemic miRNA biomarkers for patients with moderate-to-severe psoriasis. Eur J Dermatol 26, 195–198 (2016). https://doi.org/10.1684/ejd.2015.2710
Published:
Issue Date:
DOI: https://doi.org/10.1684/ejd.2015.2710